Cochrane · systematic review · CD006503
Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia
Squizzato, A, Romualdi, E, Passamonti, F, et al. · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library
HaematologyAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
5
current version
GRADE rated
5
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 5 · 100%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: patients with polycythaemia vera
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Mortality for thrombotic events [ | OR 0.2 | 2 studies · 630 participants | Moderate |
Mortality for bleedings [ | no estimate extracted | 2 studies · 630 participants | Moderate |
All‐cause mortality [ | OR 0.46 | 2 studies · 630 participants | Moderate |
Major bleeding [ | OR 0.99 | 2 studies · 630 participants | Moderate |
Minor bleeding [ | OR 1.85 | 2 studies · 630 participants | Moderate |